• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Finance

Finance

Adare Pharmaceuticals Announces Changes to Executive Leadership Team; Supports Next Phase of Growth

May 9, 2018 Microbiome Times

Adare Pharmaceuticals, Inc., today announced changes to its Leadership Team to support the next phase of its growth strategy. Since its creation in 2015, the Company has been committed to becoming a global specialty pharmaceutical […]

Finance

UAS Laboratories Expands Capabilities With New Fermentation Facility

May 6, 2018 Microbiome Times

UAS Laboratories LLC (Wausau, Wisconsin, USA), is celebrating a significant milestone with the opening of their new fermentation facility, located in Madison, Wisconsin, USA. This expansion is the result of a 60-million-dollar investment made to […]

Finance

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

May 2, 2018 Microbiome Times

Azitra Inc. today announced that it has secured $2.15 million in convertible debt financing to support advancement of the company’s pipeline of dermatology and skin care products. The financing was led by new investor Connecticut […]

Finance

Eagle Genomics Announces Senior Leadership Changes

May 2, 2018 Microbiome Times

Eagle Genomics has appointed Executive Chairman Anthony Finbow to the post of Chief Executive, with founder Abel Ureta-Vidal moving to become Chief Product Officer. The change in management structure marks a new phase for Eagle […]

Finance

Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing

April 28, 2018 Microbiome Times

A-Mansia Biotech S.A. (A-Mansia), the microbiome company focused on developing products based on the unique properties of the Akkermansia muciniphila (A. muciniphila) bacterium, today announces a €13 million first close of its Series A financing, […]

Finance

BioGaia AB – Interim management statement 1 January – 31 March 2018

April 25, 2018 Microbiome Times

Comments from the Managing Director: “Sales for the first quarter of 2018 amounted to SEK 157 million, which was an increase of 13% (excluding foreign exchange effects) compared to the corresponding period last year. Revenue […]

Finance

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery

April 20, 2018 Microbiome Times

ReviveMed Inc., today announced it has closed an oversubscribed seed round of $1.5 million to advance its artificial intelligence (AI)-driven platform that unlocks the value of metabolomics data for drug discovery and development. Rivas Capital […]

Finance

Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M

April 19, 2018 Microbiome Times

Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, announced the final close of its Series B funding round at $15.9 million with participation by existing investors Cycle […]

Finance

Inocucor Acquires Leading Crop Nutrition Company, Plans New Class of High-Performance Crop Inputs

April 17, 2018 Microbiome Times

DENVER, April 17, 2018 /PRNewswire/ — Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, announced it has acquired ATP Nutrition, a producer of science-based plant nutrients based […]

Finance

WACKER Strengthens Its Pharmaceutical-Protein Business and Buys SynCo Bio Partners

April 17, 2018 Microbiome Times

Wacker Chemie AG has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg S.à.r.l.. The Munich-based chemical company announced the acquisition today. For WACKER, […]

Finance

Synlogic Announces Registered Direct Offering of Common Stock

April 6, 2018 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that it has agreed to sell 3,280,000 shares of its common stock to a large mutual […]

Posts navigation

« 1 … 30 31 32 »

Sign Up to Free Newsletter

QIAGEN WEBINAR SERIES – REGISTER HERE

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
    May 1, 2026
  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
sign up

Sign up to the Microbiome Times newsletter